ToxMinds are specialised in ensuring product safety and compliance.


We are passionate about toxicology and how emerging developments can be utilised to provide our customers with a competitive advantage in the marketplace.

Latest News

January 2020




Our team of highly qualified (eco)toxicologists and regulatory specialists ensure that your products are safe to man and the environment and REACH compliant!


Obtaining biocidal product authorisation – ToxMinds supports companies marketing biocidal actives and products complying with the European Biocides Regulation.

Cosmetic & consumer products

Non-animal testing based safety assessment strategies for the cosmetics & consumer products industry.


Chemical risk assessment, PDE and MRL derivation services to companies from the pharmaceutical, veterinary medicines or medical device sectors.

Green biotechnology

Supporting the agribusiness and biotechnology sector with GM crop registration in accordance with the latest EFSA and EU legislative guidelines.


Application of in silico and TTC based decision tree for safety assessment of botanicals

Safety assessment of botanicals has always been a challenge, not only due to the difficulties in defining them analytically, but also due to data gaps in traditional toxicology endpoints.

Joint EFSA/ECHA guidance document for the identification of endocrine disruptors under EU Biocides and Pesticides Regulation

The European Food Safety Authority (EFSA) and the European Chemical Agency (ECHA) jointly published in June 2018 the long-awaited guidance for the identification of endocrine disruptors.


Chemical and product safety

Ensuring chemical and product safety using emerging technology and state-of-the-art risk assessment practices.

Regulatory strategy and compliance

We help you to meet the regulatory demands and to stay compliant with EU Regulations.

Product stewardship

Ensuring publicly acceptable products – We help you to communicate the safety of your product to the public.

QSAR Modelling

Predicting toxicity, identifying suitable analogues for read-across and select lead candidates through combined use of public and commercial QSAR tools.

Endocrine disruption

Identifying and assessing the evidence for chemicals to cause endocrine disruption in humans and the environment.

New risk assessment methodologies

Identifying and applying new methodologies and risk assessment approaches to support chemical safety without animal testing.


ToxMinds established, in line with EMA guidance, permitted daily exposures for more than 30 active pharmaceutical ingredients to allow managing any API residues in case of shared facility manufacturing arrangement.

Contact us